BioLife Solutions, Inc. (BLFS) Stock

About BioLife Solutions, Inc.

BioLife Solutions, Inc. is led by CEO Roderick de Greef, employs 159 people, headquartered in US, publicly traded since 1989.

BioLife Solutions, Inc. (BLFS) stock trades at $38.61 with a market capitalization of $1.89B. The stock is valued at a price-to-earnings (P/E) ratio of 36.07, price-to-book of 4.34, price-to-sales of 17.72. Over the past 52 weeks the stock has ranged between $17.86 and $39.76, and currently trades 2.9% below its 52-week high.

On profitability, BioLife Solutions, Inc. generates a return on equity (ROE) of 13.29%, return on capital employed of 1.72%, an operating margin of -12.50%, a net profit margin of 49.06%.

BioLife Solutions, Inc. by the numbers, 2016–2025

Between 2016 and 2025 BioLife Solutions, Inc. reported revenue of $8.0M rising to $96.0M, a change of +1100.0% across 10 years. Compounded, revenue has grown 14.9% a year over five years, 8.1% over three, 17.1% over the last twelve months. Net profit fell to $-12.0M.

Operating margin went from -59.0% in 2016 to -1.1% in 2025, a gain of 57.8 percentage points. The most recent net margin is 49.06%. On a trailing twelve-month basis to Jun '26, revenue is $103.0M and net profit $51.0M.

Borrowings rose from $3.0M to $18.0M, cash from operations was $20.0M in the latest year, positive in 6 of the last 10.

Return on equity has averaged -13.9% over five years, and was -3.2% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

BioLife Solutions, Inc. (BLFS) — frequently asked questions